The Missouri University Research Reactor (MURR) is the highest-power university research reactor in the U.S. It’s one of the sites where Boston Scientific’s TheraSpheres get their radioactivity. [Photo courtesy of the University of Missouri]
That radioactive power immediately begins to wane due to the half life of yttrium-90, the beta-radiation-emitting isotope in the a glass beads that slow or halt the growth of liver cancer tumors.
“As soon as they come out [of the reactor] they’re starting to decay,” Boston Scientific Interventional Oncology President Peter Pattison said in an interview.
“It’s like we’re shipping ice cubes in the desert,” he continued. “… You have to have a good process.”
Pattison — who previously explained to Medical Design & Outsourcing readers how Boston Scientific’s TheraSphere devices work, how they’re manufactured and what other cancers they might be able to treat — discussed the logistics and supply chain challenges posed by this radioactive medtech.
Nuclear reactors in the supply chain
MURR staff using the research reactor to create radioactive isotopes. [Photo courtesy of the University of Missouri]
Boston Scientific’s global network of reactors include the Missouri University Research Reactor (MURR), the Petten High Flux Reactor in the Netherlands, and reactors in Australia, Belgium, Poland and South Africa.
“These are very big, very complicated, very regulated facilities. As a result, they will go down for maintenance. Usually it’s planned maintenance, but sometimes something’s come up and they need to shut it down and do a safety check,” Pattison said.
“For us, it’s important to have a network so if we know that a reactor will go down for the next two months, that’s OK because we have four or five other reactors or more that we can draw from. It requires a lot of hand-holding from our supply chain group,” he continued.
“The most fascinating part of the process”
Employees at contract manufacturer BWXT Medical dispense radioactive TheraSphere beads inside a shielded “hot cell” using manual manipulators. [Photo courtesy of BWXT Medical]
Each dose is packaged in a 100-microliter glass vial with a Lucite shield. (Lucite is a brand name for polymethyl methacrylate, a synthetic polymer also called PMMA.) The vial and shield are packaged in a lead container to block all beta radiation, and then that’s packaged in styrofoam and a bright yellow cardboard box measuring about one cubic foot.
The dispensing employees use manual manipulators rather than electronic systems that would malfunction inside the “hot cell” due to the radiation.
A look inside a “hot cell” at the BWXT dispensing facility in Ottawa, Ontario [Photo courtesy of BWXT Medical]
Shipping radioactive devices
Boston Scientific aims for the dose to reach the interventional radiologist within two to three days, but can get it to them the next day in an emergency.
“Our ability to move in a timely fashion is world-class,” Pattison said. “We’ve had to charter aircraft at the last minute, we’ve had to send people in trucks to go get things. The hero stories — I don’t love when they happen, but I love that they turn out the right way.”
The company uses couriers rather than owning or leasing its own fleet of aircraft or delivery vehicles. To make the shipments easier for couriers to spot if they go missing in a warehouse, Boston Scientific picked a “super-bright, obnoxious” yellow color for the cardboard boxes.
“Having these bright yellow boxes for the couriers is something that’s proved to be quite helpful to us,” he said.
Boston Scientific Interventional Oncology President Peter Pattison [Photo courtesy of Boston Scientific]
“We just want the customer to worry about the dose and the day and where they are,” Pattison said. “We’ll figure out the rest of that supply chain, work back from the last-mile courier to maybe the trucking company to maybe the airline. It’s really quite astounding the detail that’s required to make sure all these packages get around the world every day.”
